Statistics for Acasti Pharma (id:6030 ACST)
Valuation metrics
Market cap
34.17M
Enterprise value
13.14M
Trailing P/E (ttm)
-1.87
Forward P/E
-2.67
PEG ratio
-2.67
Price/Sales (ttm)
Price/Book (mrq)
0.58
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.99
Overview
Shares outstanding
10.14M
Float
4.65M
Shares short
154.19K
% Held by insiders
0.38%
% Held by institutions
0.21%
Average volume (10 days)
22.41K
Average volume (90 days)
Price summary
52-Week low
1.98
52-Week high
3.60
52-Week change
34.68%
Beta
1.52
50-Day moving average
3.02
200-Day moving average
2.98
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
July 10th, 2023
Financials
Fiscal yearFiscal year ends
March 31th, 2024
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-11.62%
Return on equity
-18.56%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-13,266,000.00
Net income to common (ttm)
-11,447,000.00
Diluted EPS (ttm)
-1.43
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
19.41M
Total cash per share (mrq)
1.91
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
785.70%
Book value per share (mrq)
5.86
Cash flow
Cash flow statement
-9,689,000.00
Levered free cash flow (LFCF)
-5,580,375.00